360 Grand Est 2021


Séverine SIGRIST


General manager, innovation, medtech/biotech, outlicensing, strategy, investment


With a PhD in life sciences, Séverine Sigrist directed the research activity of the European Diabetes Study Centre for 10 years before creating Defymed in 2011, a company that develops and markets innovative implantable medical devices. She chaired the Biovalley France competitiveness cluster for 6 years, is an elected external representative on the board of the University of Strasbourg and has been President of Alsace Creation since September 2021.

This speaker will talk about

Find here the list of all the sessions presented by this speaker in order not to miss any of it.